Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | ROIV | RGEN | ||
| Company | Ascendis Pharma ADR | Roivant Sciences Ltd | Repligen Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 137.00 | 11.47 | 145.70 | ||
| High | 141.37 | 11.67 | 150.56 | ||
| Low | 135.61 | 11.41 | 143.96 | ||
| Last | 136.38 | 11.57 | 144.46 | ||
| Change | -1.36 | +0.07 | -2.08 | ||
| % Change | -0.99% | +0.61% | -1.42% | ||
| Volume | 690,200 | 16,004,100 | 1,581,500 | ||
| 20-Day Average Volume | 461,510 | 5,387,515 | 531,305 | ||
| Previous Close | 137.74 | 11.50 | 146.54 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 133.61 | 12.17 | 150.36 | ||
| 20-Day Raw Stochastic | 72.93% | 10.49% | 18.77% | ||
| 20-Day Relative Strength | 54.58% | 44.56% | 48.20% | ||
| Weighted Alpha | -0.09 | +5.98 | -19.34 | ||
| Today's Opinion | 24% Buy | 48% Buy | 8% Sell | ||
| Previous Opinion | 24% Buy | 48% Buy | 8% Buy | ||
| Last Month's Opinion | 100% Sell | 40% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.01% since 12/13/24 | -2.28% since 12/13/24 | -7.64% since 12/13/24 | ||
| Low | 130.00 on 12/16/24 | 11.41 on 12/20/24 | 143.91 on 12/19/24 | ||
| High | 141.48 on 12/17/24 | 12.22 on 12/18/24 | 161.24 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | +9.65% since 11/20/24 | +0.70% since 11/20/24 | +4.00% since 11/20/24 | ||
| Low | 122.43 on 11/21/24 | 11.41 on 12/20/24 | 136.54 on 11/21/24 | ||
| High | 141.48 on 12/17/24 | 12.94 on 11/25/24 | 161.24 on 12/16/24 | ||
| 3-Month | |||||
| %Chg | -9.84% since 09/20/24 | -3.34% since 09/20/24 | +1.04% since 09/20/24 | ||
| Low | 118.05 on 11/15/24 | 11.05 on 11/18/24 | 121.52 on 11/15/24 | ||
| High | 151.87 on 09/23/24 | 12.94 on 11/25/24 | 161.24 on 12/16/24 | ||
| 6-Month | |||||
| %Chg | +12.14% since 06/20/24 | +7.13% since 06/20/24 | +20.38% since 06/20/24 | ||
| Low | 111.09 on 09/12/24 | 10.00 on 08/05/24 | 117.63 on 07/09/24 | ||
| High | 155.53 on 09/20/24 | 13.06 on 09/09/24 | 172.65 on 08/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,270,355 | 8,422,381 | 8,093,661 | ||
| Shares Outstanding, K | 60,642 | 727,950 | 56,027 | ||
| Annual Sales | 288,670,000 | 124,800,000 | 638,760,000 | ||
| Annual Net Income | -521,070,000 | 4,348,930,000 | 41,580,000 | ||
| Last Quarter Sales | 63,590,000 | 4,480,000 | 154,870,000 | ||
| Last Quarter Net Income | -109,080,000 | -230,180,000 | -650,000 | ||
| 60-Month Beta | 0.67 | 1.25 | 0.96 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.89 on 11/14/24 | -0.29 on 11/12/24 | 0.43 on 11/12/24 | ||
| Latest Earnings Date | 02/05/25 | 02/11/25 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 106.96 | ||